Harrison.ai has petitioned the FDA to allow certain AI devices used by radiologists for medical image analysis to enter the market without review, provided they adhere to technical standards and monitoring plans. This move, if approved, could significantly reduce regulatory barriers for AI health tech but raises concerns about safety oversight. Content creators should monitor this space closely as it may signal broader shifts in FDA regulations affecting digital health products.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



